WallStreetZenWallStreetZen

NASDAQ: TELO
Telomir Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

TELO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$13.1M
Current Profit Margin
0%

TELO Return on Equity

Current Company
-1,045.4%
Current Industry
-63.5%
Current Market
188.7%
TELO's Return on Equity (-1,045.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TELO announces earnings.

TELO Return on Assets

Current Company
-542.1%
Current Industry
2.9%
TELO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TELO Return on Capital Employed

Current Company
-332.41%
Current Industry
19.5%

TELO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TELO$0.00-$11.43M-$13.07MN/AN/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
ATNM$81.00k-$45.63M-$46.45M-95.46%N/A
PSTX$64.70M-$109.04M-$123.43M+43.92%N/A
CMPX$0.00-$40.60M-$42.49MN/AN/A
View Top Biotech Stocks

Telomir Pharmaceuticals Earnings & Revenue FAQ

What were TELO's earnings last quarter?

Telomir Pharmaceuticals (NASDAQ: TELO) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Telomir Pharmaceuticals earnings for the quarter were -$9.33 million. In the same quarter last year, Telomir Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.

What was TELO's earnings growth in the past year?

As of Q2 2024, Telomir Pharmaceuticals's earnings has grown year over year. Telomir Pharmaceuticals's earnings in the past year totalled -$13.07 million.

What was TELO's revenue last quarter?

Telomir Pharmaceuticals (NASDAQ: TELO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Telomir Pharmaceuticals's revenue was $0.00.

What was TELO's revenue growth in the past year?

As of Q2 2024, Telomir Pharmaceuticals's revenue has grown null year over year. Telomir Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.